PubMed

The impact of infarct type on the reliability of early oral glucose tolerance testing in patients with myocardial infarction.

Hage C, Malmberg K, Rydén L, Wallander M.

Int J Cardiol. 2009 Oct 20. [Epub ahead of print]PMID: 19850366 [PubMed - as supplied by publisher]Related articles

Evidence for tissue factor phosphorylation and its correlation with protease activated receptor expression and the prognosis of primary breast cancer.

Rydén L, Grabau D, Schaffner F, Jönsson PE, Ruf W, Belting M.

Int J Cancer. 2009 Sep 30. [Epub ahead of print]PMID: 19795460 [PubMed - as supplied by publisher]Related articles

Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.

Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Rydén L, Luts L, Bendahl PO, Hedenfalk I.

Breast Cancer Res Treat. 2009 Oct 1. [Epub ahead of print]PMID: 19795205 [PubMed - as supplied by publisher]Related articles

Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.

Jögi A, Brennan DJ, Rydén L, Magnusson K, Fernö M, Stål O, Borgquist S, Uhlen M, Landberg G, Påhlman S, Pontén F, Jirström K.

Mod Pathol. 2009 Sep 4. [Epub ahead of print]PMID: 19734850 [PubMed - as supplied by publisher]Related articles

Letter by Settergren et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".

Settergren M, Rydén L, Pernow J.

Circulation. 2009 Sep 1;120(9):e68; author reply e69-70. No abstract available. PMID: 19720944 [PubMed - indexed for MEDLINE]Related articles

Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer.

Larsson AM, Jirström K, Fredlund E, Nilsson S, Rydén L, Landberg G, Påhlman S.

Clin Cancer Res. 2009 Sep 1;15(17):5552-9. Epub 2009 Aug 25.PMID: 19706814 [PubMed - in process]Related articles

The political power of heart doctors: with the European Heart Health Charter towards a European policy on cardiovascular disease.

O'Kelly S, Rydén L.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S58-60. No abstract available. PMID: 19675440 [PubMed - indexed for MEDLINE]Related articles

AIB1 is a predictive factor for tamoxifen response in premenopausal women.

Alkner S, Bendahl PO, Grabau D, Lövgren K, Stål O, Rydén L, Fernö M; on behalf of the South Swedish and South-East Swedish Breast Cancer Groups.

Ann Oncol. 2009 Jul 23. [Epub ahead of print]PMID: 19628566 [PubMed - as supplied by publisher]Related articles

Strategies to enhance cardiovascular disease prevention in patients with diabetes.

Anselmino M, Rydén L.

Curr Opin Cardiol. 2009 Sep;24(5):461-7.PMID: 19574921 [PubMed - in process]Related articles

Lipid lowering versus pleiotropic effects of statins on skin microvascular function in patients with dysglycaemia and coronary artery disease.

Settergren M, Böhm F, Rydén L, Pernow J, Kalani M.

J Intern Med. 2009 Nov;266(5):492-8. Epub 2009 May 7.PMID: 19563393 [PubMed - in process]Related articles

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.

Alkner S, Bendahl PO, Fernö M, Nordenskjöld B, Rydén L; South Swedish and South-East Swedish Breast Cancer Groups.

Eur J Cancer. 2009 Sep;45(14):2496-502. Epub 2009 Jun 15.PMID: 19535242 [PubMed - indexed for MEDLINE]Related articles

Effect of telmisartan on renal outcomes: a randomized trial.

Mann JF, Schmieder RE, Dyal L, McQueen MJ, Schumacher H, Pogue J, Wang X, Probstfield JL, Avezum A, Cardona-Munoz E, Dagenais GR, Diaz R, Fodor G, Maillon JM, Rydén L, Yu CM, Teo KK, Yusuf S; TRANSCEND (Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease) Investigators.

Ann Intern Med. 2009 Jul 7;151(1):1-10, W1-2. Epub 2009 May 18.PMID: 19451556 [PubMed - indexed for MEDLINE]Related articles

Reproducibility of human epidermal growth factor receptor 2 analysis in primary breast cancer: a national survey performed at pathology departments in Sweden.

Rydén L, Haglund M, Bendahl PO, Hatschek T, Kolaric A, Kovács A, Olsson A, Olsson H, Strand C, Fernö M; Swedish Her2 Analysis Group.

Acta Oncol. 2009;48(6):860-6.PMID: 19353340 [PubMed - in process]Related articles

Insulin-induced weight gain and cardiovascular events in patients with type 2 diabetes. A report from the DIGAMI 2 study.

Aas AM, Ohrvik J, Malmberg K, Rydén L, Birkeland KI; DIGAMI 2 Investigators.

Diabetes Obes Metab. 2009 Apr;11(4):323-9.PMID: 19267710 [PubMed - in process]Related articles

A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes mellitus And Diastolic Dysfunction) study.

Jarnert C, Landstedt-Hallin L, Malmberg K, Melcher A, Ohrvik J, Persson H, Rydén L.

Eur J Heart Fail. 2009 Jan;11(1):39-47.PMID: 19147455 [PubMed - indexed for MEDLINE]Related articles

Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.

Mellbin LG, Malmberg K, Waldenström A, Wedel H, Rydén L; DIGAMI 2 investigators.

Heart. 2009 May;95(9):721-7. Epub 2008 Nov 24.PMID: 19029171 [PubMed - indexed for MEDLINE]Related articles

The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements.

Rydén L, Waeber B, Ruilope LM, Mancia G, Volpe M, Holzgreve H, Mogensen CE, Laurent S.

Blood Press. 2008;17(5-6):250-9. Review.PMID: 19012063 [PubMed - indexed for MEDLINE]Related articles

Implications of abnormal glucose metabolism in patients with coronary artery disease.

Anselmino M, Wallander M, Norhammar A, Mellbin L, Rydén L.

Diab Vasc Dis Res. 2008 Nov;5(4):285-90. Review.PMID: 18958838 [PubMed - indexed for MEDLINE]Related articles

Is glucose normalization an evidence-based treatment for patients with type 2 diabetes mellitus?

Rydén L, Malmberg K, Mellbin L.

Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):8-9. Epub 2008 Oct 28. No abstract available. PMID: 18957955 [PubMed]Related articles

Left atrial velocity vector imaging for the detection and quantification of left ventricular diastolic function in type 2 diabetes.

Jarnert C, Melcher A, Caidahl K, Persson H, Rydén L, Eriksson MJ.

Eur J Heart Fail. 2008 Nov;10(11):1080-7. Epub 2008 Oct 5.PMID: 18838296 [PubMed - indexed for MEDLINE]Related articles

Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.

Borgquist S, Jögi A, Pontén F, Rydén L, Brennan DJ, Jirström K.

Breast Cancer Res. 2008;10(5):R79. Epub 2008 Sep 22.PMID: 18808688 [PubMed - indexed for MEDLINE]Related articlesFree article

[Quality assured HER2 analysis in breast cancer. Important therapeutic predictive and prognostic factor]

Fernö M, Haglund M, Bendahl PO, Olsson H, Rydén L.

Lakartidningen. 2008 Aug 6-19;105(32-33):2181-4. Swedish. No abstract available. PMID: 18780693 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular prevention in patients with diabetes and prediabetes.

Anselmino M, Gohlke H, Mellbin L, Rydén L.

Herz. 2008 Apr;33(3):170-7. Review.PMID: 18568310 [PubMed - indexed for MEDLINE]Related articles

[Diabetes and the heart - revisited]

Rydén L, Tschöpe D, Dörr R.

Herz. 2008 Apr;33(3):169. No abstract available. PMID: 18568309 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular prevention in high-risk patients with type 2 diabetes mellitus: when to start it? Reply.

Mellbin LG, Rydén L, Malmberg K, Norhammar A, Wedel H.

Eur Heart J. 2008 Jun 13. [Epub ahead of print] No abstract available. PMID: 18556714 [PubMed - as supplied by publisher]Related articles

[Time for a European perspective on cardiovascular prevention]

Nilsson PM, Perk J, Rydén L.

Lakartidningen. 2008 Apr 2-8;105(14):1000-4. Review. Swedish. No abstract available. PMID: 18478749 [PubMed - indexed for MEDLINE]Related articles

What are the risk factors for progression of coronary artery calcification in patients with type 2 diabetes?

Rydén L.

Nat Clin Pract Cardiovasc Med. 2008 Jul;5(7):370-1. Epub 2008 May 13. No abstract available. PMID: 18477984 [PubMed]Related articles

Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.

Settergren M, Böhm F, Rydén L, Pernow J.

Eur Heart J. 2008 Jul;29(14):1753-60. Epub 2008 Apr 25.PMID: 18441323 [PubMed - indexed for MEDLINE]Related articlesFree article

Early detection and integrated management of dysglycemia in cardiovascular disease: a key factor for decreasing the likelihood of future events.

Anselmino M, Mellbin L, Wallander M, Rydén L.

Rev Cardiovasc Med. 2008 Winter;9(1):29-38. Review.PMID: 18418307 [PubMed - indexed for MEDLINE]Related articles

Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.

Anselmino M, Malmberg K, Ohrvik J, Rydén L; Euro Heart Survey Investigators.

Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):216-23.PMID: 18391651 [PubMed - indexed for MEDLINE]Related articles

[Internship should give competence in medical science. The Surgical Association's curriculum proposal for all interns]

Haglund U, Frisk J, Ivarsson ML, Naredi P, Rydén L.

Lakartidningen. 2008 Feb 6-12;105(6):369-72. Swedish. No abstract available. PMID: 18380355 [PubMed - indexed for MEDLINE]Related articles

[Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary]

Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I; Grupo de trabalho da European Society of Cardiology; European Association for the Study of Diabetes.

Rev Port Cardiol. 2007 Nov;26(11):1213-74. Review. Portuguese. No abstract available. PMID: 18297842 [PubMed - indexed for MEDLINE]Related articles

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L; DIGAMI 2 Investigators.

Eur Heart J. 2008 Jan;29(2):166-76. Epub 2007 Dec 21.PMID: 18156614 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart.

Anselmino M, Ohrvik J, Malmberg K, Standl E, Rydén L; Euro Heart Survey Investigators.

Eur Heart J. 2008 Jan;29(2):177-84. Epub 2007 Dec 21.PMID: 18156611 [PubMed - indexed for MEDLINE]Related articlesFree article

Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).

Origin Trial Investigators, Gerstein H, Yusuf S, Riddle MC, Ryden L, Bosch J.

Am Heart J. 2008 Jan;155(1):26-32, 32.e1-6. Epub 2007 Nov 26.PMID: 18082485 [PubMed - indexed for MEDLINE]Related articles

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen L, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); WONCA Europe (European Society of General Practice/Family Medicine); European Heart Network (EHN); European Atherosclerosis Society (EAS).

Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113. No abstract available. PMID: 17726407 [PubMed - indexed for MEDLINE]Related articles

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN).

Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:E1-40. No abstract available. PMID: 17726406 [PubMed - indexed for MEDLINE]Related articles

Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study.

Wallander M, Malmberg K, Norhammar A, Rydén L, Tenerz A.

Diabetes Care. 2008 Jan;31(1):36-8. Epub 2007 Oct 1.PMID: 17909086 [PubMed - indexed for MEDLINE]Related articlesFree article

Increasing glucose levels and BMI predict future heart failure experience from the Reykjavík Study.

Thrainsdottir IS, Aspelund T, Gudnason V, Malmberg K, Sigurdsson G, Thorgeirsson G, Hardarson T, Rydén L.

Eur J Heart Fail. 2007 Oct;9(10):1051-7. Epub 2007 Aug 30.PMID: 17765010 [PubMed - indexed for MEDLINE]Related articles

Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free: total PSA ratios in a consecutive series of men referred for prostate biopsies.

Rydén L, Egevad L, Ekman P, Hellström M.

Scand J Urol Nephrol. 2007;41(4):302-7.PMID: 17763221 [PubMed - indexed for MEDLINE]Related articles

European guidelines on cardiovascular disease prevention in clinical practice: executive summary.

Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts), Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL; Other experts who contributed to parts of the guidelines:, Walma E, Fitzgerald T, Cooney MT, Dudina A; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Hellemans I, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A.

Eur Heart J. 2007 Oct;28(19):2375-414. Epub 2007 Aug 28. No abstract available. PMID: 17726041 [PubMed - indexed for MEDLINE]Related articlesFree article

[ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary]

Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association; European Society of Cardiology.

Rev Port Cardiol. 2007 Apr;26(4):383-446. Portuguese. No abstract available. PMID: 17695733 [PubMed - indexed for MEDLINE]Related articles

Hyperglycaemia and cardiovascular disease.

Bartnik M, Norhammar A, Rydén L.

J Intern Med. 2007 Aug;262(2):145-56. Review.PMID: 17645583 [PubMed - indexed for MEDLINE]Related articles

HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.

Rydén L, Landberg G, Stål O, Nordenskjöld B, Fernö M, Bendahl PO.

Breast Cancer Res Treat. 2008 May;109(2):351-7. Epub 2007 Jul 18.PMID: 17636399 [PubMed - indexed for MEDLINE]Related articles

Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.

Dihge L, Bendahl PO, Grabau D, Isola J, Lövgren K, Rydén L, Fernö M.

Breast Cancer Res Treat. 2008 May;109(2):255-62. Epub 2007 Jul 17.PMID: 17636398 [PubMed - indexed for MEDLINE]Related articles

Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer.

Giltnane JM, Rydén L, Cregger M, Bendahl PO, Jirström K, Rimm DL.

J Clin Oncol. 2007 Jul 20;25(21):3007-14.PMID: 17634479 [PubMed - indexed for MEDLINE]Related articles

Predictors of healthy behaviours in Swedish school children.

Villard LC, Rydén L, Ståhle A.

Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):366-72.PMID: 17568234 [PubMed - indexed for MEDLINE]Related articles

The European Heart Health Charter: towards a healthier Europe.

Rydén L, Martin J, Volqvartz S.

Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):355-6. No abstract available. PMID: 17568232 [PubMed - indexed for MEDLINE]Related articles

IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes.

Wallander M, Norhammar A, Malmberg K, Ohrvik J, Rydén L, Brismar K.

Diabetes Care. 2007 Sep;30(9):2343-8. Epub 2007 Jun 11.PMID: 17563335 [PubMed - indexed for MEDLINE]Related articlesFree article

[Guidelines on diabetes, pre-diabetes, and cardiovascular diseases]

Grupo de Trabajo sobre Diabetes y Enfermedades Cardiovasculares de la Sociedad Europea de Cardiología y de la Sociedad Europea para el Estudio de la Diabetes, Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I.

Rev Esp Cardiol. 2007 May;60(5):1e-64e. Spanish. No abstract available. PMID: 17535764 [PubMed - indexed for MEDLINE]Related articlesFree article